These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3501902)

  • 21. Long term clinical outcome of coronary surgery and assessment of the benefit obtained with postoperative aspirin and dipyridamole.
    Gershlick AH; Lyons JP; Wright JE; Sturridge MF; Layton CA; Balcon R
    Br Heart J; 1988 Aug; 60(2):111-6. PubMed ID: 3046645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of dipyridamole and aspirin on vein graft patency after coronary bypass operations.
    Chesebro JH
    Thromb Res Suppl; 1990; 12():5-10. PubMed ID: 2082487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Placebo-controlled trial of enteric coated aspirin in coronary bypass graft patients. Effect on graft patency.
    Hockings BE; Ireland MA; Gotch-Martin KF; Taylor RR
    Med J Aust; 1993 Sep; 159(6):376-8. PubMed ID: 8377686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of platelets and platelet inhibitors in aortocoronary artery vein-graft disease.
    Fuster V; Chesebro JH
    Circulation; 1986 Feb; 73(2):227-32. PubMed ID: 3510762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of antiplatelet therapy on saphenous vein coronary artery bypass graft patency.
    Sharma GV; Khuri SF; Josa M; Folland ED; Parisi AF
    Circulation; 1983 Sep; 68(3 Pt 2):II218-21. PubMed ID: 6347428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Internal mammary artery and saphenous vein graft patency. Effects of aspirin.
    Goldman S; Copeland J; Moritz T; Henderson W; Zadina K; Ovitt T; Kern KB; Sethi G; Sharma GV; Khuri S
    Circulation; 1990 Nov; 82(5 Suppl):IV237-42. PubMed ID: 2225410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of various antithrombotic regimens (aspirin, aspirin plus dipyridamole, anticoagulants) on the functional status of patients and grafts one year after coronary artery bypass grafting.
    Mulder BJ; van der Doef RM; van der Wall EE; Tijssen JG; Piek JJ; van der Meer J; Dunning AJ
    Eur Heart J; 1994 Aug; 15(8):1129-34. PubMed ID: 7988607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anticoagulants vs. low-dose aggregation inhibitors in the prevention of perioperative occlusion of aortocoronary bypass grafts. Preliminary results of a prospective randomized study].
    Pfisterer M; Jockers G; Meier B; Schmitt HE; Stulz P; Hasse J; Grädel E; Burkart F
    Helv Chir Acta; 1987 Feb; 53(4):497-500. PubMed ID: 3494713
    [No Abstract]   [Full Text] [Related]  

  • 29. [No advantage in the addition of dipyridamole or of oral anticoagulants in comparison to low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant occlusion following coronary bypass surgery].
    Houben JJ; Nicolai G
    Ned Tijdschr Geneeskd; 1993 Oct; 137(43):2225; author reply 2225-6. PubMed ID: 8247173
    [No Abstract]   [Full Text] [Related]  

  • 30. [The effect of indobufen on aortocoronary bypass patency after 1 week and after 1 year].
    Rohn V; Pirk J; Mach T
    Cor Vasa; 1993; 35(4):162-4. PubMed ID: 8403942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement of aortocoronary bypass patency by antiplatelet drug administration. Preliminary communication.
    Pirk J; Vojácek J; Kovác J
    Cor Vasa; 1986; 28(3):177-80. PubMed ID: 3527555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [No advantage in the addition of dipyridamole or of oral anticoagulants in comparison to low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant occlusion following coronary bypass surgery].
    Loeliger EA
    Ned Tijdschr Geneeskd; 1993 Oct; 137(43):2222-3. PubMed ID: 8247170
    [No Abstract]   [Full Text] [Related]  

  • 33. [Dipyridamole and low-dose aspirin in patients with aortocoronary bypass--comparison with anticoagulants].
    Loeliger EA
    Schweiz Med Wochenschr; 1988 Mar; 118(12):447-9. PubMed ID: 3259724
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy and safety of anticoagulant therapy started pre-operatively in preventing coronary vein graft occlusion.
    Yli-Mäyry S; Huikuri HV; Korhonen UR; Airaksinen KE; Ikäheimo MJ; Linnaluoto MK; Takkunen JT
    Eur Heart J; 1992 Sep; 13(9):1259-64. PubMed ID: 1396838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative study of anticoagulant management after coronary artery bypass surgery--warfarin versus dipyridamole].
    Yamaguchi A; Kitamura N; Miki T; Tatebayashi T; Kawashima M; Otaki M; Tamura H
    Nihon Kyobu Geka Gakkai Zasshi; 1992 Apr; 40(4):485-9. PubMed ID: 1613273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of dipyridamole (Persantin) on blood flow and patency of aortocoronary vein bypass grafts.
    Ekeström SA; Gunnes S; Brodin UB
    Scand J Thorac Cardiovasc Surg; 1990; 24(3):191-6. PubMed ID: 2293357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of aortocoronary vein-graft attrition with low-dose aspirin and triflusal, both associated with dipyridamole: a randomized, double-blind, placebo-controlled trial.
    Guiteras P; Altimiras J; Arís A; Augé JM; Bassons T; Bonal J; Caralps JM; Castellarnau C; Crexells C; Masotti M
    Eur Heart J; 1989 Feb; 10(2):159-67. PubMed ID: 2647494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [No advantage in the addition of dipyridamole to, or of oral anticoagulants in comparison to, a low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant stenosis following coronary bypass surgery].
    Visser J
    Ned Tijdschr Geneeskd; 1994 Feb; 138(8):426-7. PubMed ID: 8127387
    [No Abstract]   [Full Text] [Related]  

  • 39. [Dipyridamole and low-dose aspirin in patients with aortocoronary bypass--comparison with anticoagulation].
    Pfisterer M; Jockers G; Burkart F; Schmitt HE; Wolff G; Skarvan K; Stulz P; Hasse J; Grädel E
    Schweiz Med Wochenschr; 1987 Oct; 117(43):1688-92. PubMed ID: 3501162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of aorta-coronary bypass graft occlusion. Beneficial effect of ticlopidine on early and late patency rates of venous coronary bypass grafts: a double-blind study.
    Limet R; David JL; Magotteaux P; Larock MP; Rigo P
    J Thorac Cardiovasc Surg; 1987 Nov; 94(5):773-83. PubMed ID: 3312825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.